Duncan transplant patient loses drug benefit NewsOK.com, OK - Nov 29, 2008 There are no generics for the three Prograf and six Myforic pills he has to take every day. Reddin relies on his parents to pay for the drugs. ...
Source: Google News
Recent News and Articles on the Keywords: heart transplant + transplant rejection + transplant Related to the article below (Last Update: 8/7/2008)
13-year-old wins medals at US Transplant Games Loudoun Times, VA - Aug 5, 2008 Living with a heart transplant is something Jon has grown accustomed to. He takes about 15 pills every day to prevent rejection. It's something he has done ...
On heart transplant anniversary, Hazlet survivor runs 20 miles Asbury Park Press, NJ - Aug 4, 2008 Harmer, 50, has so far faced his own mortality two times, first as a heart transplant recipient at age 30 and second as a survivor of non-Hodgkin's lymphoma ...
Elliana's life depends on double lung transplant Canton Repository (subscription), OH - Aug 5, 2008 The long-term prognosis for lung transplants is never certain though he said infants tend to experience less acute rejection than older patients. ...
Softball tournament benefits heart transplant recipient Sparks Today, NV - Aug 1, 2008 Kurtis Lindsay is a 4-year-old Reno youngster who received a heart transplant in December 2006. Before he was born in November 2003, Kurtis was diagnosed ...
Linda?s Reflections? On facing a heart transplant Red Springs Citizen, NC - Jul 31, 2008 what can happen to a heart transplant recipient. And no, it?s not about contracting AIDS or developing some other disease that lurked in residual blood or ...
Blood disorder boy needs help Malaysia Star, Malaysia - Aug 1, 2008 The transplant on July 17 costs RM235,483. Marcus is to remain in Taiwan for another six months to recover if there is no rejection of the transplant. ...
Source: Google News
Acute heart transplant rejection due to Saint John's wort - F Ruschitzka, PJ Meier, M Turina, TF L?scher, G … - The Lancet, 2000 - Elsevier ... Elsevier Ltd All rights reserved. Research Letters. Acute hearttransplant rejection due to Saint John's wort. Frank Ruschitzka MD a ...
[CITATION] Acute heart transplant rejection due to St. John?s wort F Ruschitzka, PJ Meier, M Turina, TF Luscher, G … - Lancet, 2000
Source: Google Scholar
Prograf to prevent rejection of heart transplant, approved
FDA ( U.S. Food and Drug Administration ) approved Prograf ( Tacrolimus ), a drug for the prevention of graft rejection in the recipients of heart transplants.
Prograf capsules and Prograf for injection, the first products approved in the United States for heart transplantation in eight years, had been previously approved for the prevention of graft rejection in the recipients of liver and kidney transplants.
Prograf acts by a mechanism similar to Cyclosporine, another immunosuppressant used to prevent transplant rejection. Thus Prograf offers an alternative to Cyclosporine for use in certain combination immunosuppressive regimens in liver, kidney and heart transplantation.
The safety and effectiveness of Prograf-based and Cyclosporine-based immunosuppression in heart transplantation were compared in two trials, one of which was conducted in Europe and one in the U.S.
In the European trial, the survival of patients and grafts 18 months after the transplantation in the Prograf group ( 91.7% ) was similar to the Cyclosporine group ( 89.8% ).
In a U.S. study, patient and graft survival at 12 months after transplantation in the Prograf group ( 93.5% ) was similar to the Cyclosporine group ( 86.1% ).
The use of Prograf is associated with increased risk or neurotoxicity, renal function impairment, infection, and post-transplant diabetes mellitus. Like most combination immunosuppressive regimens used in solid organ transplantation, the use of Prograf-based combination immunosuppression is associated with an increased risk of malignancies, notably of non-melanoma skin cancers.
